2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester

2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester Struktur
1246616-75-0
CAS-Nr.
1246616-75-0
Englisch Name:
2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester
Synonyma:
2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester
CBNumber:
CB13371784
Summenformel:
C15H21NO7
Molgewicht:
327.33
MOL-Datei:
1246616-75-0.mol

2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester Eigenschaften

Sicherheit

2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

1-(2,2-Dimethoxyethyl)-1,4-dihydro-4-oxo-2,5-pyridinedicarboxylic Acid 2,5-Diethyl Ester is an intermediate used in the synthesis of Defluoro Dolutegravir (D228715), which is an impurity of Dolutegravir (D528800), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.

2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchemist-pharm chemical Technology Co. Ltd. 0371-67991738 13783628208
carl@alchemist-pharm.com China 1877 58

  • 2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-, 2,5-diethyl ester
  • 1246616-75-0
Copyright 2019 © ChemicalBook. All rights reserved